Hirofumi Uto

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma

Kohichiroh Yasui, Etsuko Hashimoto, Yasuji Komorizono et al. · Clinical Gastroenterology and Hepatology · 2011 · 415 citations

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima et al. · Journal of Gastroenterology · 2015 · 326 citations · Full text

Metabolic Associated Steatohepatitis, Hepatology, Metabolic Associated Steatotic Liver Disease +10

Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation

Takeshi Hori, Kenji Nagata, Satoru Hasuike et al. · Journal of Gastroenterology · 2003 · 228 citations

Surgical Oncology, Hepatology, Medicine +10

Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima et al. · Hepatology Research · 2015 · 204 citations